210 related articles for article (PubMed ID: 9342324)
1. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
[TBL] [Abstract][Full Text] [Related]
2. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.
Richter MF; Duménil G; Uzé G; Fellous M; Pellegrini S
J Biol Chem; 1998 Sep; 273(38):24723-9. PubMed ID: 9733772
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
[TBL] [Abstract][Full Text] [Related]
4. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction.
Velazquez L; Mogensen KE; Barbieri G; Fellous M; Uzé G; Pellegrini S
J Biol Chem; 1995 Feb; 270(7):3327-34. PubMed ID: 7531704
[TBL] [Abstract][Full Text] [Related]
5. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.
Yeh TC; Dondi E; Uze G; Pellegrini S
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8991-6. PubMed ID: 10908660
[TBL] [Abstract][Full Text] [Related]
6. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
7. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
8. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
[TBL] [Abstract][Full Text] [Related]
9. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
[TBL] [Abstract][Full Text] [Related]
10. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
[TBL] [Abstract][Full Text] [Related]
11. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
Ragimbeau J; Dondi E; Alcover A; Eid P; Uzé G; Pellegrini S
EMBO J; 2003 Feb; 22(3):537-47. PubMed ID: 12554654
[TBL] [Abstract][Full Text] [Related]
13. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
[TBL] [Abstract][Full Text] [Related]
14. A negative regulatory region in the intracellular domain of the human interferon-alpha receptor.
Gibbs VC; Takahashi M; Aguet M; Chuntharapai A
J Biol Chem; 1996 Nov; 271(45):28710-6. PubMed ID: 8910507
[TBL] [Abstract][Full Text] [Related]
15. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
[TBL] [Abstract][Full Text] [Related]
16. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
Walters DK; Jelinek DF
Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
[TBL] [Abstract][Full Text] [Related]
17. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
18. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
Krishnan K; Yan H; Lim JT; Krolewski JJ
Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase.
Gauzzi MC; Velazquez L; McKendry R; Mogensen KE; Fellous M; Pellegrini S
J Biol Chem; 1996 Aug; 271(34):20494-500. PubMed ID: 8702790
[TBL] [Abstract][Full Text] [Related]
20. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor.
Colamonici OR; Uyttendaele H; Domanski P; Yan H; Krolewski JJ
J Biol Chem; 1994 Feb; 269(5):3518-22. PubMed ID: 8106393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
